Olema Pharmaceuticals, Inc. (OLMA)

Olema Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	52.47	139.48	68.54	23.7	13.81	338.55
Short-Term Investments	309.44	294.61	193.27	180.72	273.44	-
Cash & Short-Term Investments	361.91	434.09	261.81	204.42	287.25	338.55
Cash Growth	51.36%	65.80%	28.07%	-28.84%	-15.15%	497766.18%
Other Receivables	2.75	2.12	0.67	0.32	0.13	-
Receivables	2.75	2.12	0.67	0.32	0.13	-
Prepaid Expenses	2.64	1.9	2.35	2.64	2.97	3.01
Other Current Assets	0.42	0.37	1.68	1.52	0.33	0.58
Total Current Assets	367.73	438.47	266.51	208.9	290.69	342.14
Property, Plant & Equipment	2.25	2.06	3.26	2.5	4.72	0.08
Long-Term Deferred Charges	0.8	0.68	-	-	-	-
Other Long-Term Assets	11.23	9.76	7.17	4.25	0.54	0.51
Total Assets	382	450.98	276.95	215.65	295.95	342.72
Accounts Payable	0.93	4.46	2.7	0.37	0.02	0.72
Accrued Expenses	31.08	36.09	17.86	15.09	7.81	3.43
Current Portion of Leases	1.15	1.17	0.99	1.02	0.93	-
Current Income Taxes Payable	-	0.04	0.07	0.07	0.09	0.2
Other Current Liabilities	-	-	-	-	0.17	0.24
Total Current Liabilities	33.16	41.76	21.62	16.55	9.02	4.59
Long-Term Leases	0.6	0.26	1.43	1.55	2.36	-
Total Liabilities	36.77	42.02	23.05	18.1	11.38	4.59
Common Stock	0.01	0.01	0	0	0	0
Additional Paid-In Capital	854.19	843.92	559.18	408.33	388.9	371.23
Retained Earnings	-509.28	-435.11	-305.63	-208.98	-104.19	-33.09
Comprehensive Income & Other	0.31	0.14	0.35	-1.81	-0.15	-
Total Common Equity	345.24	408.96	253.9	197.55	284.57	338.14
Shareholders' Equity	345.24	408.96	253.9	197.55	284.57	338.14
Total Liabilities & Equity	382	450.98	276.95	215.65	295.95	342.72
Total Debt	4.76	1.43	2.42	2.57	3.29	-
Net Cash (Debt)	357.16	432.66	259.39	201.86	283.96	338.55
Net Cash Growth	50.61%	66.80%	28.50%	-28.91%	-16.12%	497766.18%
Net Cash Per Share	4.86	7.37	5.73	5.05	7.18	48.22
Filing Date Shares Outstanding	68.63	68.33	55.91	40.63	39.85	39.43
Total Common Shares Outstanding	68.63	74.31	54.99	40.29	39.84	39.43
Working Capital	334.56	396.72	244.89	192.35	281.67	337.55
Book Value Per Share	5.03	5.50	4.62	4.90	7.14	8.57
Tangible Book Value	345.24	408.96	253.9	197.55	284.57	338.14
Tangible Book Value Per Share	5.03	5.50	4.62	4.90	7.14	8.57
Machinery	-	-	-	-	1.7	0.14

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q